Founded in 2008, Reapplix specializes in the biological treatment and management of diabetic foot ulcers. Its innovative, patented 3C Patch® System draws on the individual patient’s capacity to heal and is clinically proven to accelerate wound healing of chronic diabetic foot ulcers. Headquartered in Denmark, with sales and distribution teams in the US and Europe, Reapplix won the Danish 2018 EY Entrepreneur of the Year Award in the life science category. Our business model is supported by high quality RCT evidence published in The Lancet in September 2018 and a 2019 IWGDF Recommendation.
Mission: "Drawing on the person’s power to heal so they can get back to living their best life.”
www.reapplix.com
Company Details
- Employees
- 36
- Founded
- -
- Address
- Blokken 45, Birkerød,birkerød 3460,denmark
- Phone
- 45 45 81 19 62
- rl****@****lix.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- reapplix.com
- HQ
- Birkerød, Birkerød
Reapplix Questions
Reapplix's helpline number is 45 45 81 19 62
Reapplix's website is reapplix.com
Reapplix's LinkedIn profile is https://www.linkedin.com/company/reapplix
Reapplix has
36 employees.
View email and phone details for 36
employees at Reapplix.
Reapplix's industry is
Medical Equipment Manufacturing
Reapplix's top competitors are
Reddress Medical,
Eo2 Concepts,
Organogenesis,
Floodgate Medical,
Nuo Therapeutics, Inc.,
Kerecis,
Imbed Biosciences Inc.,
Acera Surgical,
Mimedx,
Mimosa Diagnostics.
Reapplix's support email address is rl@reapplix.com
Reapplix's categories are Medical Equipment Manufacturing
Reapplix's founding year is 2008
